In-Flight COVID Transmission: Surveying the Liability Landscape
Do airlines have legal obligations to manage the risk of in-flight infections?
Christopher Robertson
-
Read more: In-Flight COVID Transmission: Surveying the Liability Landscape -
Read more: TWIHL: Innovation and Protection: The Future of Medical Device Regulation, Episode 3 TWIHL: Innovation and Protection: The Future of Medical Device Regulation, Episode 3
This episode looks at the effects of the COVID-19 pandemic on medical device regulation in the U.S. and abroad.
-
Read more: TWIHL: Innovation and Protection: The Future of Medical Device Regulation, Episode 1 TWIHL: Innovation and Protection: The Future of Medical Device Regulation, Episode 1
The first of three episodes of “Innovation and Protection: The Future of Medical Device Regulation” looks at big-picture issues in the U.S.
-
Read more: Access to Drugs Before FDA Approval: Video Explainer with Christopher Robertson Access to Drugs Before FDA Approval: Video Explainer with Christopher Robertson
In this video explainer, Christopher Robertson discusses the Right to Try Act and off-label use of pharmaceuticals with Alison Bateman-House.
-
Read more: FDA Commissioner Rolls Back 40 Years of Orthodoxy on Cost-Exposure FDA Commissioner Rolls Back 40 Years of Orthodoxy on Cost-Exposure
Speaking yesterday at America’s Health Insurance Plans’ (AHIP) National Health Policy Conference, FDA Commissioner Scott Gottlieb railed against patient cost-exposure (e.g., copays). His prepared speech said: Patients shouldn’t be penalized by their biology if they need a drug that isn’t on formulary. Patients shouldn’t face exorbitant out of pocket costs, and pay money where the primary…
-
Read more: “Right to Try” Does Not Help Patients “Right to Try” Does Not Help Patients
Co-Blogged by Christopher Robertson and Kelly McBride Folkers (research associate at the Division of Medical Ethics of the NYU School of Medicine) In 2014, Arizonans overwhelmingly voted in favor of a ballot referendum that claimed to allow terminally ill patients the “right to try” experimental drugs that have not yet been approved by the Food…
-
Read more: Medical Bills are Open-Price Contracts: A Victory for the Little Guy Medical Bills are Open-Price Contracts: A Victory for the Little Guy
This blog has often covered the problem of outrageous medical bills, and explored whether patients have a responsibility to pay the balance on charges that are not covered by insurance. One common pattern is that the patient agrees to pay “all reasonable charges” when they arrive at the emergency room or other provider, and then…
-
Read more: Special Deals for States? Special Deals for States?
By Christopher R. Robertson Over at HuffPo, Craig Konnoth has a short-but-smart piece exploring the Constitutionality of the logrolling deals now underway to persuade Alaska Senator Lisa Murkoswki to support the latest effort to repeal Obamacare. Would other states have a right to object to a deal that showered special benefits on Alaska? Konnoth explains…
-
Read more: How the FDA Produces Knowledge (and Is Not So Weird) How the FDA Produces Knowledge (and Is Not So Weird)
The Federal government has wrested billions of dollars from the drug and device industry in settlements of claims that the companies broke the law by promoting their products “off-label” for uses not approved by the FDA. In response, companies have asserted that promotions are a form of speech, protected by the First Amendment. Speech regulations are especially…
-
Read more: Is it legal for Trump to punish health insurers that do not support repeal of Obamacare? Is it legal for Trump to punish health insurers that do not support repeal of Obamacare?
By Christopher Robertson In a recent story about how the health insurance marketplaces are being destabilized by the Trump administration’s vacillation, the LA Times reports: At one recent meeting, Seema Verma, whom Trump picked to oversee the federal Medicare and Medicaid programs, stunned insurance industry officials by suggesting a bargain: The administration would fund the…